EARNEST Partners’s Elanco Animal Health ELAN Stock Holding History

EARNEST Partners’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-190	Closed	-$2.14K	–	527
2023 Q3	$2.14K	Hold	190	–	–	﹤0.01%	987
2023 Q2	$1.91K	Hold	190	–	–	﹤0.01%	1002
2023 Q1	$1.79K	Hold	190	–	–	﹤0.01%	1003
2022 Q4	$2.32K	Hold	190	–	–	﹤0.01%	977
2022 Q3	$2K	Hold	190	–	–	﹤0.01%	960
2022 Q2	$4K	Hold	190	–	–	﹤0.01%	835
2022 Q1	$5K	Hold	190	–	–	﹤0.01%	831
2021 Q4	$5K	Hold	190	–	–	﹤0.01%	845
2021 Q3	$6K	Hold	190	–	–	﹤0.01%	788
2021 Q2	$7K	Hold	190	–	–	﹤0.01%	747
2021 Q1	$6K	Hold	190	–	–	﹤0.01%	772
2020 Q4	$6K	Hold	190	–	–	﹤0.01%	752
2020 Q3	$5K	Hold	190	–	–	﹤0.01%	752
2020 Q2	$4K	Hold	190	–	–	﹤0.01%	778
2020 Q1	$4K	Hold	190	–	–	﹤0.01%	711
2019 Q4	$6K	Hold	190	–	–	﹤0.01%	709
2019 Q3	$5K	Hold	190	–	–	﹤0.01%	744
2019 Q2	$6K	Buy	+190	New	+$6.17K	﹤0.01%	700

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EARNEST Partners's ELAN Position: Q4 2023 in Review

EARNEST Partners sold out of Elanco Animal Health (ELAN) in Q4 2023, closing a stake of 190 shares — an estimated $2.14K sold.

EARNEST Partners first reported a position in ELAN in Q2 2019 and held it in 18 quarters. The position peaked at $7K in Q2 2021. 355 funds tracked by Wall St. Rank hold ELAN as of Q4 2023.

EARNEST Partners reported no remaining Elanco Animal Health position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 190 Elanco Animal Health shares in Q4 2023, an estimated $2.14K.
EARNEST Partners first reported a position in Elanco Animal Health in Q2 2019 and held it in 18 quarters.
EARNEST Partners's Elanco Animal Health position peaked at $7K in Q2 2021.
355 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.